Hidde Bult

Articles in Scholarly Journals [Incomplete List]

  1. Stereology: a simplified and more time-efficient method than planimetry for the quantitative analysis of vascular structures in different models of intimal thickening
    Cardiovascular Pathology, vol. 16, no. 1, pp. 43–50, 2007
  2. Altered Ca2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions
    Cell Calcium, vol. 41, no. 3, pp. 295–302, 2007
  3. Gene Expression Profiling of LPS-Stimulated Murine Macrophages and Role of the NF- B and PI3K/mTOR Signaling Pathways
    Annals of the New York Academy of Sciences, vol. 1096, no. 1, pp. 70–77, 2007
  4. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model
    Cardiovascular Research, vol. 69, no. 2, pp. 536–544, 2006
  5. Endothelium-dependent relaxation evoked by ATP and UTP in the aorta of P2Y2-deficient mice
    British Journal of Pharmacology, vol. 147, no. 5, Article ID 0706642, 5 pages, 2006
  6. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease
    Coronary Artery Disease, vol. 17, no. 3, pp. 243–248, 2006
  7. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta
    British Journal of Pharmacology, vol. 146, no. 2, Article ID 0706326, 7 pages, 2005
  8. Effect of Non-Steroidal Anti-Inflammatory Drugs on Amyloid-?? Formation and Macrophage Activation after Platelet Phagocytosis
    Journal of Cardiovascular Pharmacology, vol. 43, no. 3, pp. 462–470, 2004
  9. 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling
    Cardiovascular Research, vol. 64, no. 1, pp. 144–153, 2004
  10. Drug-eluting stents: a new treatment in the prevention of restenosis
    Acta Cardiologica, vol. 59, no. 1, pp. 51–61, 2004
  11. Drug-eluting stents: a new treatment in the prevention of restenosis
    Acta Cardiologica, vol. 59, no. 2, pp. 165–177, 2004
  12. Upregulation and Formation of SDS-Resistant Oligomers of the Proapoptotic Factor Bax in Experimental Atherosclerosis
    Annals of the New York Academy of Sciences, vol. 1010, no. 1, pp. 738–741, 2003
  13. Plaque-associated endothelial dysfunction in apolipoprotein E-deficient mice on a regular diet. Effect of human apolipoprotein AI
    Cardiovascular Research, vol. 59, no. 1, pp. 189–199, 2003
  14. Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model
    Coronary Artery Disease, vol. 14, no. 8, pp. 545–555, 2003
  15. Journal of Cardiovascular Pharmacology, vol. 41, no. 6, pp. 970–978, 2003
  16. Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis
    Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 3, pp. 440–446, 2003
  17. Platelet Phagocytosis and Processing of beta-Amyloid Precursor Protein as a Mechanism of Macrophage Activation in Atherosclerosis
    Circulation Research, vol. 90, no. 11, pp. 1197–1204, 2002
  18. A Three-Dimensional Quantitative Analysis of Restenosis Parameters after Balloon Angioplasty: Comparison between Semi-Automatic Computer-Assisted Planimetry and Stereology
    Journal of Vascular Research, vol. 39, no. 5, pp. 437–446, 2002
  19. Stikstofoxidegerelateerde interventies en atherosclerose
    Tijdschrift voor Geneeskunde, vol. 58, no. 18, pp. 1181–1188, 2002
  20. Een stabiele atherosclerotische plaque als therapeutische doelstelling
    Tijdschrift voor Geneeskunde, vol. 58, no. 5, pp. 338–343, 2002
  21. Antioxidantia bij atherosclerose
    Tijdschrift voor Geneeskunde, vol. 57, no. 2, pp. 132–142, 2001
  22. Effects of local cytochalasin D delivery on smooth muscle cell migration and on collar-induced intimal hyperplasia in the rabbit carotid artery
    British Journal of Pharmacology, vol. 134, no. 3, Article ID 0704281, 10 pages, 2001
  23. Collar-induced elevation of mRNA and functional activity of 5-HT1B receptor in the rabbit carotid artery
    British Journal of Pharmacology, vol. 131, no. 8, Article ID 0703732, 8 pages, 2000
  24. Local application of advanced glycation end products and intimal hyperplasia in the rabbit collared carotid artery
    Cardiovascular Research, vol. 47, no. 1, pp. 173–182, 2000
  25. Heterogeneity in relaxation mechanisms in the carotid and the femoral artery of the mouse
    European Journal of Pharmacology, vol. 404, no. 3, pp. 341–351, 2000
  26. Restenosis: a challenge for pharmacology
    Trends in Pharmacological Sciences, vol. 21, no. 7, pp. 274–279, 2000
  27. Biochemistry, vol. 39, no. 47, pp. 14549–14557, 2000
  28. Antiatherosclerotic activity of drugs in relation to nitric oxide function
    European Journal of Pharmacology, vol. 375, no. 1-3, pp. 157–176, 1999
  29. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques
    Cardiovascular Research, vol. 43, no. 3, pp. 744–754, 1999
  30. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery
    British Journal of Pharmacology, vol. 127, no. 6, Article ID 0702684, 9 pages, 1999
  31. Histamine Synthesis by White& ;Cells during Storage of Platelet Concentrates
    Vox Sanguinis, vol. 74, no. 3, pp. 193–197, 1998
  32. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit
    Cardiovascular Research, vol. 37, no. 1, pp. 239–246, 1998
  33. The role of prostaglandin E2 and nitric oxide in cell death in J774 murine macrophages
    European Journal of Pharmacology, vol. 349, no. 2-3, pp. 307–315, 1998
  34. Nitric oxide function in atherosclerosis
    Mediators of Inflammation, vol. 6, no. 1, pp. 3–21, 1997
  35. Nitric oxide and atherosclerosis: possible implications for therapy
    Molecular Medicine Today, vol. 2, no. 12, pp. 510–518, 1996
  36. Dual effects of oxidized low-density lipoprotein on ommune-stimulated nitric oxide and prostaglandin release in macrophages
    European Journal of Pharmacology, vol. 298, no. 1, pp. 97–103, 1996
  37. Balloon angioplasty and induction of non-endothelial nitric oxide synthase in rabbit carotid arteries
    European Journal of Pharmacology, vol. 310, no. 2-3, pp. 163–174, 1996
  38. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits
    Atherosclerosis, vol. 120, no. 1-2, pp. 115–124, 1996
  39. Dexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid artery
    European Journal of Pharmacology, vol. 294, no. 2-3, pp. 753–761, 1995
  40. Modulation of nitric oxide synthase activity in macrophages
    Mediators of Inflammation, vol. 4, no. 2, pp. 75–89, 1995
  41. Oxidized Lipoproteins Suppress Nitric Oxide Synthase in Macrophages: Study of Glucocorticoid Receptor Involvement
    Mediators of Inflammation, vol. 3, no. 5, pp. 323–327, 1994
  42. Longitudinally orientated smooth muscle cells in rabbit arteries
    Virchows Archiv A Pathological Anatomy and Histopathology, vol. 422, no. 4, pp. 293–299, 1993
  43. Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-?-induced nitric oxide production by rat alveolar macrophages
    Agents and Actions, vol. 38, no. S1, pp. 100–105, 1993
  44. Soybean trypsin inhibitor and ß-amylase induce alveolar macrophages to release nitrogen oxides
    Biochemical Pharmacology, vol. 44, no. 2, pp. 387–390, 1992
  45. Diminished capacity to release metabolites of nitric oxide synthase in macrophages loaded with oxidized low-density lipoproteins
    European Journal of Pharmacology, vol. 212, no. 1, pp. 113–115, 1992
  46. Synergism between interleukin-1ß and interferon-?, an inducer of nitric oxide synthase, in rat lung fibroblasts
    European Journal of Pharmacology, vol. 224, no. 1, pp. 7–12, 1992
  47. Ridogrel prevents the thromboxane-mediated presser response and oedema induced by hydrogen peroxide in isolated rabbit lungs
    European Journal of Pharmacology, vol. 201, no. 1, pp. 83–90, 1991
  48. L-Arginine-dependent production of nitrogen oxides by rat pulmonary macrophages
    European Journal of Pharmacology, vol. 200, no. 2-3, pp. 205–209, 1991
  49. Dipyridamole potentiates the anti-aggregating and vasodilator activity of nitric oxide
    European Journal of Pharmacology, vol. 199, no. 1, pp. 1–8, 1991
  50. Early atherosclerosis is accompanied by a decreased rather than an increased accumulation of fatty acid hydroxyderivatives
    Biochemical Pharmacology, vol. 42, no. 2, pp. 279–283, 1991
  51. Thromboxane and prostacyclin production in the perfused rabbit lung
    Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 43, no. 4, pp. 239–246, 1991
  52. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter
    Nature, vol. 345, no. 6273, Article ID 345346a0, 1 pages, 1990
  53. The effect of a developing neo-intima on serotonergic and adrenergic contractions
    European Journal of Pharmacology, vol. 187, no. 3, pp. 519–524, 1990
  54. Non-adrenergic non-cholinergic relaxation mediated by nitric oxide in the canine ileocolonic junction
    European Journal of Pharmacology, vol. 190, no. 1-2, pp. 239–246, 1990
  55. EDRF(s) and EDRF-related substances Antwerp, Belgium 28–30 June 1990
    Trends in Pharmacological Sciences, vol. 11, no. 9, p. 344, 1990
  56. Evidence for the involvement of prostaglandins in modulation of acetylcholine release from canine bronchial tissue
    European Journal of Pharmacology, vol. 167, no. 3, pp. 415–418, 1989
  57. Evaluation of the functional integrity of endothelium in perfused lungs
    Agents and Actions, vol. 26, no. 1-2, pp. 258–260, 1989
  58. Dexamethasone and prostacyclin biosynthesis by serosal membranes of the rabbit peritoneal cavity
    Agents and Actions, vol. 17, no. 3-4, pp. 308–309, 1986
  59. Complement-dependent stimulation of prostacyclin biosynthesis: inhibition by rosmarinic acid
    Biochemical Pharmacology, vol. 35, no. 8, pp. 1397–1400, 1986
  60. Modulation of prostacyclin biosynthesis by calcium entry blockers and extracellular calcium
    Biochemical Pharmacology, vol. 35, no. 23, pp. 253–256, 1986
  61. Effects of dexamethasone on prostacyclin biosynthesis in rabbit mesothelial cells
    Prostaglandins, vol. 32, no. 2, pp. 169–178, 1986
  62. Inhibition of rabbit platelet activation by lipoxygenase products of arachidonic and linoleic acid
    Thrombosis Research, vol. 42, no. 2, pp. 205–214, 1986
  63. Mechanism of complement-induced stimulation of prostacyclin production by isolated rabbit peritoneum
    Prostaglandins, vol. 25, no. 2, pp. 245–261, 1983
  64. Inflammatory mediators released by complement-derived peptides
    Agents and Actions, vol. 13, no. 5-6, pp. 405–414, 1983
  65. Complement factor C5-derived split products stimulate prostacyclin production by rabbit aorta endothelium
    Agents and Actions, vol. 13, no. 5-6, pp. 433–434, 1983
  66. Activation of rabbit blood platelets by endotoxin: Significance of thromboxane biosynthesis and release reaction
    Agents and Actions, vol. 13, no. 5-6, pp. 501–503, 1983
  67. Influence of endotoxin on arachidonate metabolism in isolated rabbit peritoneum
    Biochemical Pharmacology, vol. 32, no. 17, pp. 2523–2528, 1983
  68. Relationship between prostacyclin biosynthesis and cyclic AMP in cultured rabbit mesothelial cells
    Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 322, no. 3, pp. 245–248, 1983
  69. Activated complement and anaphylatioxins increase the in vitro production of prostacyclin by rabbit aorta endothelium
    Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 322, no. 2, pp. 158–165, 1983
  70. Isolation and Pharmacological Characterization of Vernolepin
    Journal of Natural Products, vol. 46, no. 2, pp. 161–169, 1983
  71. Contribution of complement activation to the rise in blood levels of 6-oxo-prostaglandin F1a during endotoxin-induced hypotension in rabbits
    European Journal of Pharmacology, vol. 79, no. 1-2, pp. 91–99, 1982
  72. Prostanoids and hemostasis in chickens: Anti-aggregating activity of the prostaglandins E1 and E2, but not of prostacyclin and prostaglandin D2
    Prostaglandins, vol. 21, no. 6, pp. 1045–1058, 1981
  73. Blood levels of 6-oxo-prostaglandin F1a during endotoxin-induced hypotension in rabbits
    European Journal of Pharmacology, vol. 63, no. 1, pp. 47–56, 1980
  74. Thromboxane A2 biosynthesis during endotoxin-induced aggregation of platelets from normal and sensitized guinea-pigs
    Agents and Actions, vol. 9, no. 5-6, pp. 560–565, 1979
  75. Inflammatory models in rats depleted of endogenous precursors of prostaglandins
    Agents and Actions, vol. 8, no. 1-2, pp. 98–101, 1978
  76. Prostaglandin endoperoxides, serotonin and the superfused rabbit aorta: Possible pitfalls in the bio-assay of rabbit aorta contracting substance (RCS)
    Agents and Actions, vol. 6, no. 6, pp. 712–720, 1976
  77. Essential fatty acid deficiency: A condition to discriminate prostaglandin and non-prostaglandin mediated components of inflammation
    Agents and Actions, vol. 6, no. 1-3, pp. 154–158, 1976
  78. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides
    Nature, vol. 264, no. 5585, Article ID 264449a0, 2 pages, 1976
  79. Equivolumetric Glycerol and Sucrose Gradients for the B-XIV and B-XV Zonal Rotors
    European Journal of Biochemistry, vol. 28, no. 4, pp. 463–474, 1972
  80. Die Verwendung von Natriumsuperoxyd
    Zeitschrift für Analytische Chemie, vol. 34, no. 1, pp. 593–598, 1895